TY  - JOUR
AU  - García-Guerrero, Estefanía
AU  - Sierro-Martínez, Belén
AU  - Pérez-Simón, Jose Antonio
PY  - 2020
DO  - 10.3389/fimmu.2020.01128
UR  - http://hdl.handle.net/10668/15819
T2  - Frontiers in immunology
AB  - Multiple myeloma (MM) remains an incurable disease regardless of recent advances in the field. Therefore, a substantial unmet need exists to treat patients with relapsed/refractory myeloma. The use of novel agents such as daratumumab, elotuzumab,...
LA  - en
KW  - CAR T-cell
KW  - allogeneic CAR T-cell
KW  - antigen escape
KW  - myeloma
KW  - soluble protein
KW  - toxicities
KW  - Humans
KW  - Immunotherapy, Adoptive
KW  - Multiple Myeloma
KW  - Receptors, Chimeric Antigen
TI  - Overcoming Chimeric Antigen Receptor (CAR) Modified T-Cell Therapy Limitations in Multiple Myeloma.
TY  - research article
VL  - 11
ER  -